Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2017 Filed Aug 2, 2017 20:56 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 5,363 | $152.25 | $816,516.75 |
DisclosureSEC source: 0001209191-17-047139 · doc4.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,092 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $152.25 (range $151.79 to 152.77). F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:56 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
Exercise / conversionCommon Stock | 11,063 | $45.11 | $499,051.93 |
DisclosureSEC source: 0001209191-17-047139 · doc4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2017 Filed Jul 21, 2017 23:58 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,125 | $0.00 Strike: $131.89 | $0.00 |
DisclosureSEC source: 0001209191-17-046024 · doc4.xml · derivative · entry 16 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 2,125 shares Expires 2025-07-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests in 16 quarterly installments from 07/21/2015. Read SEC document |
| July 21, 2017 Filed Jul 21, 2017 23:58 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 200 | $161.72 | $32,344.00 |
DisclosureSEC source: 0001209191-17-046024 · doc4.xml · nonDerivative · entry 10 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,117 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1. Read SEC document |
| July 21, 2017 Filed Jul 21, 2017 23:58 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 10,150 | $161.68 | $1,641,052.00 |
DisclosureSEC source: 0001209191-17-046024 · doc4.xml · nonDerivative · entry 9 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,317 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1. Read SEC document |
| July 21, 2017 Filed Jul 21, 2017 23:58 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 2,125 | $159.00 | $337,875.00 |
DisclosureSEC source: 0001209191-17-046024 · doc4.xml · nonDerivative · entry 8 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,467 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1. Read SEC document |
| July 21, 2017 Filed Jul 21, 2017 23:58 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionCommon Stock | 2,125 | $131.89 | $280,266.25 |
DisclosureSEC source: 0001209191-17-046024 · doc4.xml · nonDerivative · entry 7 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:02 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 1,336 | $162.04 | $216,485.44 |
DisclosureSEC source: 0001209191-17-046026 · doc4.xml · nonDerivative · entry 8 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,424 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $162.04 (range $161.90 to $162.38). Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:02 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 3,464 | $161.38 | $559,020.32 |
DisclosureSEC source: 0001209191-17-046026 · doc4.xml · nonDerivative · entry 7 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,760 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $161.38 (range $160.90 to $161.89). Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:02 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 400 | $159.85 | $63,940.00 |
DisclosureSEC source: 0001209191-17-046026 · doc4.xml · nonDerivative · entry 6 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,224 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $159.85 (range $159.64 to $160.25). Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:02 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 1,000 | $158.92 | $158,920.00 |
DisclosureSEC source: 0001209191-17-046026 · doc4.xml · nonDerivative · entry 5 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,624 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $158.92 (range $158.61 to $159.48). Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:02 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 700 | $158.08 | $110,656.00 |
DisclosureSEC source: 0001209191-17-046026 · doc4.xml · nonDerivative · entry 4 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,624 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $158.08 (range $157.48 to $158.41). F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:04 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 5,058 | $162.08 | $819,800.64 |
DisclosureSEC source: 0001209191-17-046027 · doc4.xml · nonDerivative · entry 9 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,392 F1 · kind: Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F8 · price: Open market sales reported on this line occurred at a weighted average price of $162.08 (range $161.92 to $162.45). Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:04 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 17,255 | $161.43 | $2,785,474.65 |
DisclosureSEC source: 0001209191-17-046027 · doc4.xml · nonDerivative · entry 8 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,450 F1 · kind: Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $161.43 (range $160.92 to $161.91). Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:04 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 900 | $160.42 | $144,378.00 |
DisclosureSEC source: 0001209191-17-046027 · doc4.xml · nonDerivative · entry 7 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,705 F1 · kind: Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $160.42 (range $159.90 to $160.86). Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:04 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 3,500 | $159.34 | $557,690.00 |
DisclosureSEC source: 0001209191-17-046027 · doc4.xml · nonDerivative · entry 6 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,605 F1 · kind: Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $159.34 (range $158.89 to $159.77). Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:04 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 4,837 | $158.46 | $766,471.02 |
DisclosureSEC source: 0001209191-17-046027 · doc4.xml · nonDerivative · entry 5 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,105 F1 · kind: Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $158.46 (range $157.88 to $158.86). Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:04 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 700 | $157.42 | $110,194.00 |
DisclosureSEC source: 0001209191-17-046027 · doc4.xml · nonDerivative · entry 4 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,942 F1 · kind: Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $157.42 (range $156.81 to $157.71). F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:07 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 1,564 | $162.07 | $253,477.48 |
DisclosureSEC source: 0001209191-17-046029 · doc4.xml · nonDerivative · entry 7 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,710 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $162.07 (range $161.90 to $162.43). Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:07 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 4,461 | $161.44 | $720,183.84 |
DisclosureSEC source: 0001209191-17-046029 · doc4.xml · nonDerivative · entry 6 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,274 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $161.44 (range $160.90 to $161.89) Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:07 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 500 | $160.04 | $80,020.00 |
DisclosureSEC source: 0001209191-17-046029 · doc4.xml · nonDerivative · entry 5 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,735 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $160.04 (range $159.64 to $160.25). Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:07 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 1,300 | $158.90 | $206,570.00 |
DisclosureSEC source: 0001209191-17-046029 · doc4.xml · nonDerivative · entry 4 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,235 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $158.90 (range $158.61 to $159.53). Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:07 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 800 | $158.05 | $126,440.00 |
DisclosureSEC source: 0001209191-17-046029 · doc4.xml · nonDerivative · entry 3 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,535 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $158.05 (range $157.48 to $158.37). F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:09 UTC |
SMITH IAN FEVP, CFO & COO
|
SaleCommon Stock | 200 | $162.40 | $32,480.00 |
DisclosureSEC source: 0001209191-17-046030 · doc4.xml · nonDerivative · entry 11 SMITH IAN F · CIK 0001197032 · EVP, CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,888 F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F8 · price: Open market sales reported on this line occurred at a weighted average price of $162.40 (range $162.39 to $162.40). Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:09 UTC |
SMITH IAN FEVP, CFO & COO
|
SaleCommon Stock | 5,106 | $161.71 | $825,691.26 |
DisclosureSEC source: 0001209191-17-046030 · doc4.xml · nonDerivative · entry 10 SMITH IAN F · CIK 0001197032 · EVP, CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,088 F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $161.71 (range $161.28 to $162.20). Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:09 UTC |
SMITH IAN FEVP, CFO & COO
|
SaleCommon Stock | 2,000 | $161.01 | $322,020.00 |
DisclosureSEC source: 0001209191-17-046030 · doc4.xml · nonDerivative · entry 9 SMITH IAN F · CIK 0001197032 · EVP, CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,194 F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $161.01 (range $160.28 to $161.24). Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:09 UTC |
SMITH IAN FEVP, CFO & COO
|
SaleCommon Stock | 815 | $159.61 | $130,082.15 |
DisclosureSEC source: 0001209191-17-046030 · doc4.xml · nonDerivative · entry 8 SMITH IAN F · CIK 0001197032 · EVP, CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,194 F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $159.61 (range $159.16 to $159.90). Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:09 UTC |
SMITH IAN FEVP, CFO & COO
|
SaleCommon Stock | 1,829 | $158.62 | $290,115.98 |
DisclosureSEC source: 0001209191-17-046030 · doc4.xml · nonDerivative · entry 7 SMITH IAN F · CIK 0001197032 · EVP, CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,009 F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $158.62 (range $158.11 to $159.09). Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:09 UTC |
SMITH IAN FEVP, CFO & COO
|
SaleCommon Stock | 400 | $157.56 | $63,024.00 |
DisclosureSEC source: 0001209191-17-046030 · doc4.xml · nonDerivative · entry 6 SMITH IAN F · CIK 0001197032 · EVP, CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,838 F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $157.56 (range $156.99 to $157.90). F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:10 UTC |
Silva Paul MSVP & Corp Controller
|
SaleCommon Stock | 500 | $161.92 | $80,960.00 |
DisclosureSEC source: 0001209191-17-046031 · doc4.xml · nonDerivative · entry 11 Silva Paul M · CIK 0001446372 · SVP & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,634 F1 · kind: Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1. Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 00:10 UTC |
Silva Paul MSVP & Corp Controller
|
SaleCommon Stock | 2,937 | $161.91 | $475,529.67 |
DisclosureSEC source: 0001209191-17-046031 · doc4.xml · nonDerivative · entry 10 Silva Paul M · CIK 0001446372 · SVP & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,134 F1 · kind: Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1. Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 23:58 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,775 | $0.00 Strike: $91.05 | $0.00 |
DisclosureSEC source: 0001209191-17-046024 · doc4.xml · derivative · entry 15 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,707 Underlying: Common Stock · 10,775 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/02/2016. Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 23:58 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 14,875 | $0.00 Strike: $131.89 | $0.00 |
DisclosureSEC source: 0001209191-17-046024 · doc4.xml · derivative · entry 14 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,125 Underlying: Common Stock · 14,875 shares Expires 2025-07-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests in 16 quarterly installments from 07/21/2015. Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 23:58 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 38,250 | $0.00 Strike: $109.14 | $0.00 |
DisclosureSEC source: 0001209191-17-046024 · doc4.xml · derivative · entry 13 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,250 Underlying: Common Stock · 38,250 shares Expires 2025-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/03/2015. Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 23:58 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,500 | $0.00 Strike: $96.87 | $0.00 |
DisclosureSEC source: 0001209191-17-046024 · doc4.xml · derivative · entry 12 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 25,500 shares Expires 2024-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 07/15/2014. Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 23:58 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 29,000 | $162.67 | $4,717,430.00 |
DisclosureSEC source: 0001209191-17-046024 · doc4.xml · nonDerivative · entry 6 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,467 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1. Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 23:58 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 60,400 | $161.00 | $9,724,400.00 |
DisclosureSEC source: 0001209191-17-046024 · doc4.xml · nonDerivative · entry 5 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,467 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1. Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 23:58 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionCommon Stock | 10,775 | $91.05 | $981,063.75 |
DisclosureSEC source: 0001209191-17-046024 · doc4.xml · nonDerivative · entry 4 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,867 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 23:58 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionCommon Stock | 14,875 | $131.89 | $1,961,863.75 |
DisclosureSEC source: 0001209191-17-046024 · doc4.xml · nonDerivative · entry 3 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,092 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 23:58 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionCommon Stock | 38,250 | $109.14 | $4,174,605.00 |
DisclosureSEC source: 0001209191-17-046024 · doc4.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,217 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 23:58 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionCommon Stock | 25,500 | $96.87 | $2,470,185.00 |
DisclosureSEC source: 0001209191-17-046024 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 19, 2017 Filed Jul 22, 2017 00:00 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $81.54 | $0.00 |
DisclosureSEC source: 0001209191-17-046025 · doc4.xml · derivative · entry 5 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| July 19, 2017 Filed Jul 22, 2017 00:00 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,979 | $0.00 Strike: $91.05 | $0.00 |
DisclosureSEC source: 0001209191-17-046025 · doc4.xml · derivative · entry 4 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,756 Underlying: Common Stock · 8,979 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/02/2016. Read SEC document |
| July 19, 2017 Filed Jul 22, 2017 00:00 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 28,979 | $161.00 | $4,665,619.00 |
DisclosureSEC source: 0001209191-17-046025 · doc4.xml · nonDerivative · entry 3 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,011 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. Read SEC document |
| July 19, 2017 Filed Jul 22, 2017 00:00 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Exercise / conversionCommon Stock | 20,000 | $81.54 | $1,630,800.00 |
DisclosureSEC source: 0001209191-17-046025 · doc4.xml · nonDerivative · entry 2 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,990 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 19, 2017 Filed Jul 22, 2017 00:00 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Exercise / conversionCommon Stock | 8,979 | $91.05 | $817,537.95 |
DisclosureSEC source: 0001209191-17-046025 · doc4.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,990 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 19, 2017 Filed Jul 22, 2017 00:02 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 32,343 | $0.00 Strike: $109.14 | $0.00 |
DisclosureSEC source: 0001209191-17-046026 · doc4.xml · derivative · entry 10 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,157 Underlying: Common Stock · 32,343 shares Expires 2025-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The option vests in 16 quarterly installments from 2/3/2015. Read SEC document |
| July 19, 2017 Filed Jul 22, 2017 00:02 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,303 | $0.00 Strike: $96.87 | $0.00 |
DisclosureSEC source: 0001209191-17-046026 · doc4.xml · derivative · entry 9 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,875 Underlying: Common Stock · 6,303 shares Expires 2024-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option vests in 16 quarterly installments from 7/15/2014. Read SEC document |
| July 19, 2017 Filed Jul 22, 2017 00:02 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 39,833 | $161.00 | $6,413,113.00 |
DisclosureSEC source: 0001209191-17-046026 · doc4.xml · nonDerivative · entry 3 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,324 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. Read SEC document |
| July 19, 2017 Filed Jul 22, 2017 00:02 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
Exercise / conversionCommon Stock | 32,343 | $109.14 | $3,529,915.02 |
DisclosureSEC source: 0001209191-17-046026 · doc4.xml · nonDerivative · entry 2 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.